Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

glaxosmithkline ΜΟΝΟΠΡΟΣΩΠΗ ΑΝΩΝΥΜΗ ΕΜΠΟΡΙΚΗ ΚΑΙ ΒΙΟΜΗΧΑΝΙΚΗ ΕΤΑΙΡΕΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΠΡΟΪΟΝΤΩΝ Δ.Τ. glaxosmithkline ΜΟΝΟΠΡΟΣΩΠΗ Α.Ε.Β.Ε. Λεωφ. Κηφισίας 266,, 152 32 152 32, Χαλάνδρι 210-6882100 - diphtheria toxoid, adsorbed; tetanus toxoid; pertussis toxoid (pt); filamentous haemagglutinin (fha); pertactin (69 kda outer membrane protein-69k); inactivated poliovirus vacc type i; inactivated poliovirus vacc type ii; inactivated poliovirus vacc type iii - inj.susp (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ) - diphtheria toxoid, adsorbed 0 => 2iu; tetanus toxoid 0 => 20iu; pertussis toxoid (pt) 8mcg; filamentous haemagglutinin (fha) 8mcg; pertactin (69 kda outer membrane protein-69k) 2,5mcg; inactivated poliovirus vacc type i 40du; inactivated poliovirus vacc type ii 8du; inactivated poliovirus vacc type iii 32du - diphtheria-pertussis-poliomyelitis-tetanus

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

sanofi pasteur europe, france 14 espace henry vallee, 69007 lyon +33 437 28 40 00 - diphtheria toxoid, adsorbed; tetanus toxoid, adsorbed; purified pertussis toxoid (pt xd); adsorbed purified filamentous haemagglutinin (fha); adsorbed purified pertactin (prn); adsorbed purified fimbrial agglutinogens 2+3 (fim); inactivated poliovirus vacc type i; inactivated poliovirus vacc type ii; inactivated poliovirus vacc type iii; aluminium phosphate - inj.su.pfs (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ ΣΕ ΠΡΟΓΕΜΙΣΜΕΝΗ ΣΥΡΙΓΓΑ) - diphtheria toxoid, adsorbed 2iu; tetanus toxoid, adsorbed 20iu; purified pertussis toxoid (pt xd) 2,5mcg; adsorbed purified filamentous haemagglutinin (fha) 5mcg; adsorbed purified pertactin (prn) 3mcg; adsorbed purified fimbrial agglutinogens 2+3 (fim) 5mcg; inactivated poliovirus vacc type i 29u; inactivated poliovirus vacc type ii 7u; inactivated poliovirus vacc type iii 26u; aluminium phosphate 1,5mg - diphtheria-pertussis-poliomyelitis-tetanus

Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

sanofi pasteur. (0000010487) 14 espace henry vallee, lyon, 69007 - diphtheria toxoid; tetanus toxoid; bordetella pertussis antigens toxoid; bordetella pertussis antigens filamentous haemagglutinin; formalinavd\dat poliovirus typ 1 (stam brunenders); formalinavd\dat poliovirus typ 2 (stam mef1); formalinavd\dat poliovirus typ 3 (stam saukett) - suspension for injection in pre-filled syringe - diphtheria toxoid (8000000804) 30iu; tetanus toxoid (8000040440) 40iu; bordetella pertussis antigens toxoid (8000002964) 25ug; bordetella pertussis antigens filamentous haemagglutinin (8000003163) 25ug; formalinavd\dat poliovirus typ 1 (stam brunenders) (8000037458) 40du; formalinavd\dat poliovirus typ 2 (stam mef1) (8000037469) 8du; formalinavd\dat poliovirus typ 3 (stam saukett) (8000037470) 32du - diphtheria-pertussis-poliomyelitis-tetanus

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

glaxosmithkline ΜΟΝΟΠΡΟΣΩΠΗ ΑΝΩΝΥΜΗ ΕΜΠΟΡΙΚΗ ΚΑΙ ΒΙΟΜΗΧΑΝΙΚΗ ΕΤΑΙΡΕΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΠΡΟΪΟΝΤΩΝ Δ.Τ. glaxosmithkline ΜΟΝΟΠΡΟΣΩΠΗ Α.Ε.Β.Ε. Λεωφ. Κηφισίας 266,, 152 32 152 32, Χαλάνδρι 210-6882100 - filamentous haemagglutinin (fha); pertactin (69 kda outer membrane protein-69k); pertussis toxoid (pt); diphtheria toxoid, adsorbed; tetanus toxoid; inactivated poliovirus vacc type i; inactivated poliovirus vacc type ii; inactivated poliovirus vacc type iii - inj.su.pfs (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ ΣΕ ΠΡΟΓΕΜΙΣΜΕΝΗ ΣΥΡΙΓΓΑ) - 0,5ml/dose (pfs) - filamentous haemagglutinin (fha) 25; pertactin (69 kda outer membrane protein-69k) 8g; pertussis toxoid (pt) 25g; diphtheria toxoid, adsorbed 30iu; tetanus toxoid 40iu; inactivated poliovirus vacc type i 40du; inactivated poliovirus vacc type ii 8du; inactivated poliovirus vacc type iii 32du - diphtheria-pertussis-poliomyelitis-tetanus

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

ΕΛΛΗΝΙΚΟ ΙΝΣΤΙΤΟΥΤΟ ΠΑΣΤΕΡ Βασ.Σοφίας 127,, 115 21 115 21, Αθήνα 6462281, 6430044 - purified diphteria toxoid; purified tetanus toxoid; purified pertussis toxoid (pt xd); filamentous haemagglutinin (fha); inactivated poliovirus vacc type i; inactivated poliovirus vacc type ii; inactivated poliovirus vacc type iii - inj.susp (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ) - (1 dose) 0,5ml pf.syr - purified diphteria toxoid; purified tetanus toxoid; purified pertussis toxoid (pt xd); filamentous haemagglutinin (fha); inactivated poliovirus vacc type i; inactivated poliovirus vacc type ii; inactivated poliovirus vacc type iii - diphtheria-pertussis-poliomyelitis-tetanus

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

sanofi pasteur europe, france 14 espace henry vallee, 69007 lyon +33 437 28 40 00 - purified diphteria toxoid; purified tetanus toxoid; purified pertussis toxoid (pt xd); filamentous haemagglutinin (fha); inactivated poliovirus vacc type i; inactivated poliovirus vacc type ii; inactivated poliovirus vacc type iii - inj.susp (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ) - (1ΔΟΣΗ)0,5ml pf.syr. - purified diphteria toxoid 20iu; purified tetanus toxoid 40iu; purified pertussis toxoid (pt xd) 25mcg; filamentous haemagglutinin (fha) 25mcg; inactivated poliovirus vacc type i 29du; inactivated poliovirus vacc type ii 7du; inactivated poliovirus vacc type iii 26du - diphtheria-pertussis-poliomyelitis-tetanus

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

vianex a.e. - diphtheria-pertussis-poliomyelitis-tetanus - ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - ΕΜΒΟΛΙΑ

Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

glaxosmithkline biologicals sa (0000003483) rue de l΄ institut 89, rixensart, b-1330 - tetanus toxoid; pertactin (69kda outer membrane protein-prn); inactivated polio virus type 1; inactivated polio virus type 2; inactivated polio virus type 3; pertussis toxoid(pt); filamentous haemagglutinin (fha); diphtheria toxoid - suspension for injection - tetanus toxoid (8000024353) 40du; pertactin (69kda outer membrane protein-prn) (8000002317) 8mcg; inactivated polio virus type 1 (8000002316) 40du; inactivated polio virus type 2 (8000002314) 8du; inactivated polio virus type 3 (8000002313) 32du; pertussis toxoid(pt) (8000001811) 25mcg; filamentous haemagglutinin (fha) (8000001813) 25mcg; diphtheria toxoid (8000000804) 30iu - diphtheria-pertussis-poliomyelitis-tetanus